These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 26555162)

  • 1. Evaluation of the use of non-pathogenic porcine circovirus type 1 as a vaccine delivery virus vector to express antigenic epitopes of porcine reproductive and respiratory syndrome virus.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Opriessnig T; Tian D; Heffron CL; Meng XJ
    Virus Res; 2016 Feb; 213():100-108. PubMed ID: 26555162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
    Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacing the decoy epitope of PCV2 capsid protein with epitopes of GP3 and/or GP5 of PRRSV enhances the immunogenicity of bivalent vaccines in mice.
    Jung BK; Kim HR; Jang H; Chang KS
    J Virol Methods; 2020 Oct; 284():113928. PubMed ID: 32650038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
    Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
    Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2.
    Xu XG; Wang ZS; Zhang Q; Li ZC; Ding L; Li W; Wu HY; Chang CD; Lee LH; Tong DW; Liu HJ
    J Virol Methods; 2012 Feb; 179(2):359-66. PubMed ID: 22172969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
    J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of recombinant vaccinia virus vaccines co-expressing GP3/GP5 of European PRRSV and Cap protein of PCV2 in pigs.
    Han J; Ma H; Cao L; Jing J; Xiao P; Sun W; Xie C; Wen S; Li Y; Tian M; Lu H; Jin N
    Appl Microbiol Biotechnol; 2018 Feb; 102(3):1145-1154. PubMed ID: 29189898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric porcine circoviruses (PCV) containing amino acid epitope tags in the C terminus of the capsid gene are infectious and elicit both anti-epitope tag antibodies and anti-PCV type 2 neutralizing antibodies in pigs.
    Beach NM; Smith SM; Ramamoorthy S; Meng XJ
    J Virol; 2011 May; 85(9):4591-5. PubMed ID: 21307200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
    J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
    Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
    Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Displaying epitope B and epitope 7 of porcine reproductive and respiratory syndrome virus on virus like particles of porcine circovirus type 2 provides partial protection to pigs.
    Li G; Liu L; Xu B; Hu J; Kuang H; Wang X; Wang L; Cui X; Sun H; Rong J
    J Vet Med Sci; 2021 Aug; 83(8):1263-1272. PubMed ID: 34234054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.
    Ren J; Lu H; Wen S; Sun W; Yan F; Chen X; Jing J; Liu H; Liu C; Xue F; Xiao P; Xin S; Jin N
    J Virol Methods; 2014 Sep; 206():27-37. PubMed ID: 24882496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine reproductive and respiratory syndrome virus as a vector: immunogenicity of green fluorescent protein and porcine circovirus type 2 capsid expressed from dedicated subgenomic RNAs.
    Pei Y; Hodgins DC; Wu J; Welch SK; Calvert JG; Li G; Du Y; Song C; Yoo D
    Virology; 2009 Jun; 389(1-2):91-9. PubMed ID: 19423145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition.
    Trible BR; Ramirez A; Suddith A; Fuller A; Kerrigan M; Hesse R; Nietfeld J; Guo B; Thacker E; Rowland RR
    Vaccine; 2012 Jun; 30(27):4079-85. PubMed ID: 22521847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant porcine circovirus type 2 expressing the VP1 epitope of the type O foot-and-mouth disease virus is infectious and induce both PCV2 and VP1 epitope antibodies.
    Huang L; Zhang F; Tang Q; Wei Y; Wu H; Guo L; Fu Y; Liu C
    Appl Microbiol Biotechnol; 2014 Nov; 98(22):9339-50. PubMed ID: 25117547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodies.
    Vanhee M; Van Breedam W; Costers S; Geldhof M; Noppe Y; Nauwynck H
    Vaccine; 2011 Jun; 29(29-30):4794-804. PubMed ID: 21554913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and identification of a recombinant PRRSV expressing ORF2 of porcine circovirus type 2].
    Zhang T; Liu X; Sun T; Zhu X; Fan B; Bai J; Jiang P
    Bing Du Xue Bao; 2015 Jan; 31(1):65-73. PubMed ID: 25997333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
    Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
    Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
    Opriessnig T; Shen HG; Pal N; Ramamoorthy S; Huang YW; Lager KM; Beach NM; Halbur PG; Meng XJ
    Clin Vaccine Immunol; 2011 Aug; 18(8):1261-8. PubMed ID: 21653745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.